According to MarketsandMarkets™, the High Flow Nasal Cannula Market is projected to reach USD 1.44 billion by 2031 from USD 0.94 billion in 2026, at a CAGR of 8.9% during the forecast period.

Three main methods of noninvasive support are used in the acute care setting: a high flow of gas delivered through a large-bore nonocclusive nasal cannula (i.e., high-flow nasal cannula), continuous ...

High-flow nasal cannula therapy is as safe and efficacious as conventional modes of noninvasive ventilation (NIV) in preterm infants, according to a meta-analysis published online August 17 and in the ...

The American College of Physicians (ACP) today released a new Clinical Guideline with recommendations for the appropriate use of high-flow nasal oxygen in hospitalized patients for initial or ...

As the COVID-19 pandemic continues, increasing the number of patients suffering from respiratory conditions and requiring respiratory support, softFlow offers clinicians across the continuum of care ...

Please provide your email address to receive an email when new articles are posted on . Researchers assessed high-flow nasal therapy in two sequences. The changes in dyspnea and respiratory drive with ...

High-flow nasal oxygen (HFNO) is noninferior to noninvasive ventilation (NIV) for endotracheal intubation or death within seven days for most patients with acute respiratory failure, according to a ...

Please provide your email address to receive an email when new articles are posted on . Patients with severe interstitial lung disease who received heated and humidified nasal high-flow oxygen therapy ...

Hypoxemia is the most common complication of emergency endotracheal intubation of children, with an incidence of up to 50%. In this randomized trial of children under 16 years, nasal high-flow oxygen ...

According to MarketsandMarkets, the High Flow Nasal Cannula Market is projected to reach USD 1.44 billion by 2031 from USD 0.94 billion in 2026 ...